drugset / Trial / NCT00666341

Dose-Response-Study With a Recombinant Cocktail of Phleum (rPhleum) Allergens

NCT00666341 ↗

Phase 2 Completed 50 enrolled Allergopharma GmbH & Co. KG
RandomizedParallel-groupTriple-blindTreatment

Summary

Dose-response trial with a cocktail of recombinant major allergens of Timothy Grass Pollen (Phleum pratense)

Timeline

Start
2007-09
Primary completion
2009-01
Completion
2010-05

Drugs

EvaluationDrugModalityDoseRoute
Subject rPhleum Protein / enzyme biologic 20 ug —
Subject rPhleum Protein / enzyme biologic 40 ug —
Subject rPhleum Protein / enzyme biologic 80 ug —
Subject rPhleum Protein / enzyme biologic 120 ug —